Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Protara Therapeutics (Nasdaq: TARA), a clinical-stage company focused on developing therapies for cancer and rare diseases, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The company's management will present on Monday, September 9, 2024, at 1:30 pm ET in New York.
Investors and interested parties can access a live webcast of the presentation through the Events and Presentations section of Protara's website at https://ir.protaratx.com. The webcast will be available for a time after the presentation concludes, providing an opportunity for those unable to attend the live event to catch up on the company's latest developments and strategic outlook.
Protara Therapeutics (Nasdaq: TARA), una società in fase clinica focalizzata nello sviluppo di terapie per il cancro e malattie rare, ha annunciato la sua partecipazione alla 26a Conferenza Annuale Globale sugli Investimenti H.C. Wainwright. La direzione della società presenterà lunedì 9 settembre 2024, alle 13:30 ET a New York.
Investitori e parti interessate possono accedere a un webcast live della presentazione attraverso la sezione Eventi e Presentazioni sul sito di Protara all'indirizzo https://ir.protaratx.com. Il webcast sarà disponibile per un periodo dopo la conclusione della presentazione, offrendo così l'opportunità a coloro che non possono partecipare all'evento dal vivo di aggiornarsi sugli ultimi sviluppi e sulle prospettive strategiche della società.
Protara Therapeutics (Nasdaq: TARA), una empresa en etapa clínica centrada en el desarrollo de terapias para cáncer y enfermedades raras, ha anunciado su participación en la 26ª Conferencia Anual Global de Inversión H.C. Wainwright. La dirección de la empresa presentará el lunes 9 de septiembre de 2024, a la 1:30 p. m. ET en Nueva York.
Los inversores y las partes interesadas pueden acceder a un webcast en vivo de la presentación a través de la sección de Eventos y Presentaciones en el sitio web de Protara en https://ir.protaratx.com. El webcast estará disponible por un tiempo después de que concluya la presentación, brindando así la oportunidad para aquellos que no pueden asistir al evento en vivo de ponerse al día sobre los últimos desarrollos y las perspectivas estratégicas de la empresa.
Protara Therapeutics (Nasdaq: TARA), 희귀 질환과 암 치료제 개발에 집중하는 임상 단계 회사가 H.C. Wainwright 제26회 세계 투자 컨퍼런스에 참가한다고 발표했습니다. 회사 경영진은 2024년 9월 9일 월요일 오후 1시 30분 ET에 뉴욕에서 발표할 예정입니다.
투자자 및 관심 있는 분들은 Protara 웹사이트의 이벤트 및 발표 섹션에서 발표의 라이브 웹캐스트에 접근할 수 있습니다: https://ir.protaratx.com. 웹캐스트는 발표가 끝난 후 일정 시간 동안 이용 가능하여, 라이브 이벤트에 참석하지 못한 분들이 회사의 최신 개발 사항 및 전략적 전망을 파악할 수 있는 기회를 제공합니다.
Protara Therapeutics (Nasdaq: TARA), une entreprise en phase clinique axée sur le développement de thérapies pour le cancer et les maladies rares, a annoncé sa participation à la 26e Conférence Annuelle Mondiale sur les Investissements H.C. Wainwright. La direction de l'entreprise présentera le lundi 9 septembre 2024, à 13h30 ET à New York.
Les investisseurs et les parties intéressées peuvent accéder à un webcast en direct de la présentation via la section Événements et Présentations du site de Protara à https://ir.protaratx.com. Le webcast sera disponible pendant un certain temps après la fin de la présentation, offrant ainsi l'opportunité à ceux qui ne peuvent pas assister à l'événement en direct de se mettre à jour sur les derniers développements et les perspectives stratégiques de l'entreprise.
Protara Therapeutics (Nasdaq: TARA), ein Unternehmen in der klinischen Phase, das sich auf die Entwicklung von Therapien für Krebs und seltene Krankheiten konzentriert, hat seine Teilnahme an der 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright bekannt gegeben. Das Management des Unternehmens wird am Montag, den 9. September 2024, um 13:30 Uhr ET in New York präsentieren.
Investoren und Interessierte können über den Bereich Veranstaltungen und Präsentationen auf der Website von Protara auf einen Live-Webcast der Präsentation zugreifen unter https://ir.protaratx.com. Der Webcast wird eine Zeit lang nach Abschluss der Präsentation verfügbar sein, sodass diejenigen, die nicht an der Live-Veranstaltung teilnehmen können, die neuesten Entwicklungen und die strategische Outlook des Unternehmens nachholen können.
- None.
- None.
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on Monday, September 9, 2024 at 1:30 pm ET.
A live webcast of the presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcast will be archived for a limited time following the presentation.
About Protara Therapeutics, Inc.
Protara is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead candidate, TARA-002, an investigational cell-based therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). The Company is evaluating TARA-002 in an ongoing Phase 2 trial in NMIBC patients with carcinoma in situ (CIS) who are unresponsive or naïve to treatment with Bacillus Calmette-Guérin (BCG), as well as a Phase 2 trial in pediatric patients with LMs. Additionally, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement for patients on parenteral nutrition who are otherwise unable to meet their choline needs via oral or enteral routes. For more information, visit www.protaratx.com.
Company Contact:
Justine O'Malley
Protara Therapeutics
Justine.OMalley@protaratx.com
646-817-2836
FAQ
When is Protara Therapeutics (TARA) presenting at the H.C. Wainwright Global Investment Conference?
How can I watch Protara Therapeutics' (TARA) presentation at the investment conference?
What does Protara Therapeutics (TARA) specialize in?
Will Protara Therapeutics' (TARA) conference presentation be available after the live event?
